1,060 filings
Page 17 of 53
DEFA14A
EYPT
EyePoint Pharmaceuticals Inc
16 Oct 20
Additional proxy soliciting materials
12:46pm
DEF 14A
EYPT
EyePoint Pharmaceuticals Inc
Definitive proxy
16 Oct 20
7:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
8 Oct 20
EyePoint Pharmaceuticals Announces Amendment to CRG Debt Facility Modifying 2020 and 2021 Revenue Covenants
7:05am
8-K
EYPT
EyePoint Pharmaceuticals Inc
7 Oct 20
EyePoint Pharmaceuticals Announces Preliminary Net Product Revenue for Third Quarter 2020
8:05am
PRE 14A
EYPT
EyePoint Pharmaceuticals Inc
Preliminary proxy
6 Oct 20
4:41pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
15 Sep 20
Other Events
4:00pm
4
EYPT
EyePoint Pharmaceuticals Inc
9 Sep 20
EyePoint Pharmaceuticals / George Elston ownership change
9:16am
4
George Elston
26 Aug 20
EyePoint Pharmaceuticals / George Elston ownership change
9:21am
8-K
EYPT
EyePoint Pharmaceuticals Inc
20 Aug 20
EyePoint Pharmaceuticals Receives $9.5 Million in Upfront Cash from Ocumension Therapeutics Under Expanded License Agreements
7:05am
8-K
EYPT
EyePoint Pharmaceuticals Inc
12 Aug 20
Other Events
4:06pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
6 Aug 20
Entry into a Material Definitive Agreement
4:08pm
424B5
EYPT
EyePoint Pharmaceuticals Inc
5 Aug 20
Prospectus supplement for primary offering
9:16am
8-K
EYPT
EyePoint Pharmaceuticals Inc
5 Aug 20
Entry into a Material Definitive Agreement
8:21am
10-Q
2020 Q2
EYPT
EyePoint Pharmaceuticals Inc
Quarterly report
5 Aug 20
7:15am
8-K
EYPT
EyePoint Pharmaceuticals Inc
5 Aug 20
EyePoint Pharmaceuticals Reports Second Quarter 2020 Financial Results and Highlights Recent Corporate Developments
7:05am
8-K
EYPT
EyePoint Pharmaceuticals Inc
13 Jul 20
EyePoint Pharmaceuticals Expands Executive Leadership Team with the Appointment of Jay S. Duker, M.D., as Chief Strategic Scientific Officer
4:40pm
4
David Scott Jones
2 Jul 20
EyePoint Pharmaceuticals / David Scott Jones ownership change
6:15pm
4
Dario A. Paggiarino
2 Jul 20
EyePoint Pharmaceuticals / Dario A. Paggiarino ownership change
6:14pm
4
Nancy Lurker
2 Jul 20
EyePoint Pharmaceuticals / Nancy Lurker ownership change
6:13pm
4
EYPT
EyePoint Pharmaceuticals Inc
30 Jun 20
EyePoint Pharmaceuticals / Dario A. Paggiarino ownership change
7:52pm